US Congress House Bill 4207 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 11-0)
Status: Introduced on December 9 2015 - 25% progression, died in committee
Action: 2015-12-11 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Medicare Fair Drug Pricing Act of 2015 This bill amends title XVIII (Medicare) of the Social Security Act to require the Centers for Medicare & Medicaid Services (CMS) to negotiate with drug manufacturers in determining the price that may be charged for prescription drugs under the Medicare prescription drug benefit. Under current law, CMS may not interfere with negotiations between drug manufacturers and prescription drug plan (PDP) sponsors. The bill creates an exception to this prohibition with respect to specified drugs that: (1) are single-source or biological, (2) are not both manufactured by more than two drug manufacturers and manufactured by at least one manufacturer as a generic drug, and (3) meet other specified requirements. CMS must promulgate regulations regarding the identification of such drugs. With respect to these drugs, CMS shall negotiate the price that may be charged to PDP sponsors and Medicare Advantage (MA) organizations for Medicare and MA enrollees. The bill establishes processes for negotiation and price determination in the initial plan year and subsequent plan years. A manufacturer must participate in the negotiation process as a condition of coverage under the Medicare prescription drug benefit.

Medicare Fair Drug Pricing Act of 2015

Rep. Janice Schakowsky [D-IL]	Rep. Lloyd Doggett [D-TX]	Rep. Barbara Lee [D-CA]	Rep. Mark Pocan [D-WI]
Rep. Rosa DeLauro [D-CT]	Rep. Jim McDermott [D-WA]	Sen. Peter Welch [D-VT]	Rep. Elijah Cummings [D-MD]
Rep. Bennie Thompson [D-MS]	Rep. Michael Honda [D-CA]	Rep. Earl Blumenauer [D-OR]

Date	Chamber	Action
2015-12-11	House	Referred to the Subcommittee on Health.
2015-12-09	House	Referred to the Subcommittee on Health.
2015-12-09	House	Referred to House Ways and Means
2015-12-09	House	Referred to House Energy and Commerce
2015-12-09	House	Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2015-12-09	House	Introduced in House

Type	Source
Summary	https://www.congress.gov/bill/114th-congress/house-bill/4207/all-info
Text	https://www.congress.gov/114/bills/hr4207/BILLS-114hr4207ih.pdf